<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01052337</url>
  </required_header>
  <id_info>
    <org_study_id>Blade-runner</org_study_id>
    <nct_id>NCT01052337</nct_id>
  </id_info>
  <brief_title>Anesthesia Induction in Patients Undergoing Surgery for Cervical Myelopathy</brief_title>
  <acronym>Blade runner</acronym>
  <official_title>Anesthesia Induction With Propofol or Sevoflurane in Patients Undergoing Fiberoptic Intubation for Cervical Myelopathy: Effects on Heamodynamics</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Roma La Sapienza</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Roma La Sapienza</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Aim of this trial is to compare propofol-based anaesthesia vs. sevoflurane-based anaesthesia&#xD;
      induction in patients with cervical myelopathy receiving oral or nasal fiberoptic intubation.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Background: Fiberoptic intubation is the preferred method of intubation in patients with&#xD;
      acute symptoms or signs of cervical myelopathy. This approach minimizes cervical spine&#xD;
      movements to prevent new neurologic deficits or further neurologic injury, and is the safer&#xD;
      method to secure the airways in patients with foreseen difficult intubation. In these&#xD;
      patients anaesthesia induction is aimed to prevent cervical spine movements and to maintain&#xD;
      hemodynamic stability. The most commonly reported technique for anaesthesia induction in&#xD;
      patients with cervical myelopathy is based on local anaesthesia and propofol administration.&#xD;
      Aim of this trial is to compare propofol-based anaesthesia vs. sevoflurane-based anaesthesia&#xD;
      induction in patients with cervical myelopathy receiving oral or nasal fiberoptic intubation.&#xD;
&#xD;
      Methods: This randomized controlled trial is designed to prove equivalence. A series of 116&#xD;
      patients aged between 18 and 75 years, with cervical myelopathy will be enrolled. In all&#xD;
      patients topical anaesthesia will be accomplished before anaesthesia induction. Patients will&#xD;
      be randomly assigned to one of two anaesthesia induction strategies (sevoflurane + O2 + air&#xD;
      or propofol + O2 + air). When loss of consciousness occurs (indicated by Bispectral index&#xD;
      values between 40 and 50), oral or nasal fiberoptic intubation will be performed. The&#xD;
      hemodynamic effects of the anaesthesia induction strategies will be assessed measuring mean&#xD;
      arterial pressure at 4 time points: before anaesthesia induction (T1: baseline), at the end&#xD;
      of anaesthesia induction when an adequate sedation level, with Bispectral index values 40-50,&#xD;
      is achieved (T2: sedation steady state); immediately after placement of endotracheal tube&#xD;
      (T3: intubation); five minute after tracheal intubation (T4: post-intubation). Secondary&#xD;
      end-points of the study include the incidence of apnoea during induction process, diagnosed&#xD;
      as absence of carbon dioxide trace for more than 10 seconds, the incidence of induction&#xD;
      complications, defined as presence of laryngospasm, coughing and patient movement, and&#xD;
      intubation conditions, defined as cord opening.&#xD;
&#xD;
      Discussion: We present the development phase of this anaesthesiological trial. A total of 40&#xD;
      patients have been enrolled from April 2009.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>April 2009</start_date>
  <primary_completion_date type="Anticipated">March 2010</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>episode of severe arterial hypotension</measure>
    <time_frame>at 0 minut, after 3 minuts, after 5 minuts</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>the incidence and duration of apnoea and the incidence of induction complications such as laryngospasm, coughing and patient movement during fiberoptic intubation.</measure>
    <time_frame>at 0 minuts , at 5 minuts</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">116</enrollment>
  <condition>Spinal Cord Diseases</condition>
  <arm_group>
    <arm_group_label>propofol</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>sevofluorane</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>anaesthetics: sevofluorane</intervention_name>
    <description>0.5%of sevofluorane with air</description>
    <arm_group_label>propofol</arm_group_label>
    <arm_group_label>sevofluorane</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patient undergoing cervical spine surgery;&#xD;
&#xD;
          -  Male or female;&#xD;
&#xD;
          -  Aged 18-75 years.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Severe cardiovascular pathology;&#xD;
&#xD;
          -  Liver disease;&#xD;
&#xD;
          -  Renal disease;&#xD;
&#xD;
          -  BMI &gt;35;&#xD;
&#xD;
          -  Allergies to any anaesthetic drugs.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Federico F Bilotta</last_name>
    <phone>+39 339 33 70 822</phone>
    <email>bilotta@tiscali.it</email>
  </overall_contact>
  <location>
    <facility>
      <name>Policlinico UMBERTO I</name>
      <address>
        <city>Rome</city>
        <zip>00100</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Federico F Bilotta</last_name>
      <phone>+39 339 33 70 822</phone>
      <email>bilotta@tiscali.it</email>
    </contact>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>December 2009</verification_date>
  <study_first_submitted>January 12, 2010</study_first_submitted>
  <study_first_submitted_qc>January 19, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 20, 2010</study_first_posted>
  <last_update_submitted>January 19, 2010</last_update_submitted>
  <last_update_submitted_qc>January 19, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 20, 2010</last_update_posted>
  <responsible_party>
    <name_title>Federico Bilotta</name_title>
    <organization>Policlinico Umberto I</organization>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Spinal Cord Diseases</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anesthetics</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

